ArticleActa pharmaceutica Sinica. B2026

VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters.

Chenchen Ge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.